Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study

scientific article published on 03 June 2011

Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11255-011-9997-7
P698PubMed publication ID21637988

P50authorRahul KathariyaQ82470265
P2093author name stringA R Pradeep
Anuj Sharma
N M Raghavendra
P Arjun Raju
R Sushma Rani
P2860cites workInterleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P componentQ24294475
A new equation to estimate glomerular filtration rateQ24651973
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationQ28283679
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationQ29547560
Relationship between periodontal disease and systemic healthQ30048803
Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infectionsQ33217837
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humansQ33912738
Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patientsQ34083517
PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammationQ34106947
Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular diseaseQ80316793
Increased expression of long pentraxin PTX3 in inflammatory bowel diseasesQ81569125
A prediction model for chronic kidney disease includes periodontal diseaseQ83378594
Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levelsQ86062645
Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activationQ34128052
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes.Q34324823
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarctionQ34357988
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertilityQ34403569
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.Q34450228
Assessing kidney function--measured and estimated glomerular filtration rateQ34535861
Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.Q34683473
Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, MarylandQ35564197
Lifestyle risk factors and chronic kidney diseaseQ35576423
Preventing chronic kidney disease in special populationsQ36101361
Unraveling the racial disparities associated with kidney diseaseQ36232245
Systemic markers of inflammation in periodontitisQ36309253
New insights on inflammation in chronic kidney disease-genetic and non-genetic factorsQ36556972
Systemic humoral immune responses in periodontal diseaseQ37836119
Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patientsQ37875355
Immunologic function and survival in hemodialysis patients.Q39470116
Detection of high-risk groups and individuals for periodontal diseases. Evidence for the existence of high-risk groups and individuals and approaches to their detection.Q39651967
Enzymatic Penetration Through Intact Sulcular EpitheliumQ40002877
Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysisQ40365204
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinQ40738906
Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) studyQ42652365
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney diseaseQ43637056
Periodontal disease and other nontraditional risk factors for CKD.Q43671721
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortalityQ44571381
Inflammation and subclinical infection in chronic kidney disease: a molecular approachQ44636956
Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulatorsQ46118909
Glycemic status and development of kidney disease: the Framingham Heart StudyQ46722312
Antiviral activity of the long chain pentraxin PTX3 against influenza virusesQ46739811
Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.Q46749995
A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings.Q51802780
Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.Q51932753
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.Q53496784
Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.Q55043442
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisQ56942761
Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restrictionQ56942827
Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)Q56943278
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failureQ58950361
Bacterial invasion of gingiva in advanced periodontitis in humansQ72037914
PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITYQ76726210
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventiQ79267289
Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetesQ79678572
[The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses]Q79835871
P433issue3
P921main subjectkidney diseaseQ1054718
P304page(s)829-839
P577publication date2011-06-03
P1433published inInternational Urology and NephrologyQ15763616
P1476titleRisk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study
P478volume44

Reverse relations

cites work (P2860)
Q36200128Biochemical analysis of pentraxin 3 and fibrinogen levels in experimental periodontitis model
Q36463833Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.
Q41835260On the occasion of world kidney day 2017; obesity and its relationship with chronic kidney disease
Q49400168PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis
Q37621780Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.
Q33873248Risk factors for chronic kidney disease: an update

Search more.